Baudax Bio Inc (BXRXQ)
OTCMKTS: BXRXQ · Delayed Price · USD
0.00
0.00 (0.00%)
No quote available

Baudax Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018 2017
Revenue
1.271.080.4900
Upgrade
Revenue Growth (YoY)
17.50%119.07%---
Upgrade
Cost of Revenue
7.012.451.7300
Upgrade
Gross Profit
-5.74-1.37-1.2400
Upgrade
Selling, General & Admin
24.1245.3143.3427.0129.45
Upgrade
Research & Development
3.893.139.0920.0635.58
Upgrade
Other Operating Expenses
25.842.582.1500
Upgrade
Operating Expenses
53.8451.0154.5747.0765.04
Upgrade
Operating Income
-59.58-52.38-55.81-47.07-65.04
Upgrade
Interest Expense / Income
001.3600
Upgrade
Other Expense / Income
-0.79-32.6118.93-14.528.63
Upgrade
Pretax Income
-58.8-19.77-76.1-32.56-73.67
Upgrade
Net Income
-58.8-19.77-76.1-32.56-73.67
Upgrade
Shares Outstanding (Basic)
00000
Upgrade
Shares Outstanding (Diluted)
00000
Upgrade
Shares Change
505.82%311.07%99.37%--
Upgrade
EPS (Basic)
-177.30-361.16-5714.80-4872.01-11032.01
Upgrade
EPS (Diluted)
-177.30-361.16-5714.80-4872.01-11032.01
Upgrade
Free Cash Flow
-27.81-49.47-44.7-51.53-63.2
Upgrade
Free Cash Flow Per Share
-83.87-903.82-3356.64-7714.85-9462.84
Upgrade
Gross Margin
-452.32%-126.39%-251.32%--
Upgrade
Operating Margin
-4695.11%-4849.63%-11319.88%--
Upgrade
Profit Margin
-4633.18%-1830.46%-15436.11%--
Upgrade
Free Cash Flow Margin
-2191.73%-4580.83%-9066.33%--
Upgrade
EBITDA
-56.63-16.95-72.19-32.08-73.27
Upgrade
EBITDA Margin
-4462.81%-1569.72%-14642.39%--
Upgrade
Depreciation & Amortization
2.162.822.550.480.4
Upgrade
EBIT
-58.8-19.77-74.74-32.56-73.67
Upgrade
EBIT Margin
-4633.18%-1830.46%-15160.45%--
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).